Omics Derived Biomarkers and Novel Drug Targets for Improved Intervention in Advanced Prostate Cancer

Prostate cancer (PCa) is one of the most frequently diagnosed malignancies, and the fifth leading cause of cancer related mortality in men. For advanced PCa, radical prostatectomy, radiotherapy, and/or long-term androgen deprivation therapy are the recommended treatment options. However, subsequent...

Descripción completa

Detalles Bibliográficos
Autores principales: Frantzi, Maria, Hupe, Marie C., Merseburger, Axel S., Schanstra, Joost P., Mischak, Harald, Latosinska, Agnieszka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555799/
https://www.ncbi.nlm.nih.gov/pubmed/32878288
http://dx.doi.org/10.3390/diagnostics10090658

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555799/
https://www.ncbi.nlm.nih.gov/pubmed/32878288
http://dx.doi.org/10.3390/diagnostics10090658

Ejemplares similares